Clinical Trials Logo

Atopic Dermatitis (AD) clinical trials

View clinical trials related to Atopic Dermatitis (AD).

Filter by:
  • No longer available  
  • Page 1

NCT ID: NCT04159597 No longer available - Clinical trials for Atopic Dermatitis (AD)

Expanded Access to Upadacitinib

Start date: n/a
Phase:
Study type: Expanded Access

This is an expanded access program (EAP) for eligible participants. This program is designed to provide access to upadacitinib prior to approval by the local regulatory agency. Availability will depend on territory eligibility. A medical doctor must decide whether the potential benefit outweighs the risk of receiving an investigational therapy based on the individual patient's medical history and program eligibility criteria.